Jefferies Upgrades Azelis & IMCD: Positive Specialty Chemicals Outlook
Jefferies upgrades Azelis and IMCD to 'buy' amid recovery in organic revenue and strategic updates from new CEOs.
- Latest
- Trending
Jefferies upgrades Azelis and IMCD to 'buy' amid recovery in organic revenue and strategic updates from new CEOs.
Gap's Q2 earnings report exceeded forecasts, with EPS at $0.54 and revenue at $3.7B, topping estimates before official release.
Okta boosts annual guidance after Q2 results beat estimates, driven by new business gains, lifting shares by over 4%.
Crypto analyst predicts Bitcoin bullish setup; updates on Solana and Polygon.
NVIDIA launches AI weather model enhancing short-term forecasts, predicting extreme events, potentially saving lives.
Dream Unlimited reports Q2 earnings of $55.5M, a major recovery from last year's loss, driven by strong income properties.
Discover insights into Ethereum's price trajectory using predictive algorithms and market trends.
Exploring the risks of AI model collapse and its potential impact on technology and business for a sustainable future.
Home Depot revises 2024 outlook, forecasting decline in sales and earnings amid economic uncertainty and high interest rates.
Intuitive Machines sees revenue doubling in Q2 2024, forecasting $210-240M full-year, with key mission progress.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.